WuXi XDC Cayman (STU:L74) Change In Inventory: €0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:L74 WuXi XDC Cayman Inc STU:L74
50 GF Score
Price €7.50
! 3 Warning Signs
View Full Analysis

What is WuXi XDC Cayman Change In Inventory?

WuXi XDC Cayman STU:L74 -5.06% 50 Change In Inventory is €0.0 Mil as of Dec. 2025. GuruFocus rates STU:L74 with a GF Score™ of 50/100. The stock has 3 warning signs investors should review.

WuXi XDC Cayman's change in inventory for the quarter that ended in Dec. 2025 was €0.0 Mil. It means WuXi XDC Cayman's inventory stayed the same from Jun. 2025 to Dec. 2025 .

WuXi XDC Cayman's change in inventory for the fiscal year that ended in Dec. 2025 was €-8.0 Mil. It means WuXi XDC Cayman's inventory increased by €8.0 Mil from Dec. 2024 to Dec. 2025 .

WuXi XDC Cayman's Total Inventories for the quarter that ended in Dec. 2025 was €21.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. WuXi XDC Cayman's Days Inventory for the quarter that ended in Dec. 2025 was 15.56.

Inventory Turnover measures how fast the company turns over its inventory within a year. WuXi XDC Cayman's Inventory Turnover for the quarter that ended in Dec. 2025 was 11.73.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. WuXi XDC Cayman's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.05.

WuXi XDC Cayman  (STU:L74) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

WuXi XDC Cayman's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=21.4925/252.119*365 / 2
=15.56

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

WuXi XDC Cayman's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=252.119 / 21.4925
=11.73

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

WuXi XDC Cayman's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=21.4925 / 393.265
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Change In Inventory Related Terms

WuXi XDC Cayman Change In Inventory Historical Data

* Premium members only.

The historical data trend for WuXi XDC Cayman's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WuXi XDC Cayman Change In Inventory Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial -2.29 -5.32 1.91 -11.13 -7.95

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:L74
50GF Score
WuXi XDC Cayman Inc STU:L74
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WuXi XDC Cayman Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €0.0 Mil mean?
WuXi XDC Cayman (STU:L74) has a Change In Inventory of €0.0 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for WuXi XDC Cayman and its competitors.
Is WuXi XDC Cayman's Change In Inventory too high?
WuXi XDC Cayman's current Change In Inventory is €0.0 Mil. Overall, WuXi XDC Cayman has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does WuXi XDC Cayman's Change In Inventory compare to TMO and DHR?
WuXi XDC Cayman's Change In Inventory of €0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Diagnostics & Research company?
A good Change In Inventory depends on the Medical Diagnostics & Research industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for WuXi XDC Cayman and its competitors. WuXi XDC Cayman's current Change In Inventory is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WuXi XDC Cayman stock overvalued right now?
WuXi XDC Cayman (STU:L74) has a current Change In Inventory of €0.0 Mil. The current Change In Inventory is €0.0 Mil. WuXi XDC Cayman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For WuXi XDC Cayman (STU:L74), the current Change In Inventory is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WuXi XDC Cayman Business Description

Other Exchanges 02268:Hong KongL74:Germany
Address No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN
WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.
50GF Score

Get the complete analysis for STU:L74

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.50
Price